Citadel Advisors’s Hinge Health HNGE Stock Holding History
Bought
Maintained
Sold
Other funds holding HNGE
Citadel Advisors's HNGE Position: Q3 2026 in Review
Citadel Advisors reduced its Hinge Health (HNGE) stake by 90% in Q3 2026, selling an estimated $59.8M and leaving 76,380 shares worth $7.43M. The position accounts for ﹤0.01% of the portfolio, ranked #4155.
Citadel Advisors first reported a position in HNGE in Q2 2025 and has held it in 6 quarters since. The position peaked at $62.9M in Q2 2026. 368 funds tracked by Wall St. Rank hold HNGE as of Q3 2026.
- Citadel Advisors held 76,380 shares of Hinge Health worth $7.43M as of Q3 2026.
- Citadel Advisors sold 681,730 Hinge Health shares in Q3 2026, an estimated $59.8M.
- Hinge Health made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #4155 holding.
- Citadel Advisors first reported a position in Hinge Health in Q2 2025 and has held it in 6 quarters since.
- Citadel Advisors's Hinge Health position peaked at $62.9M in Q2 2026.
- 368 funds tracked by Wall St. Rank held Hinge Health as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.